Stoke Therapeutics, Inc. (STOK): 8-K filed Sep 25, 2026

Form type

8-K

Filing date

Sep 25, 2026

Accession number

0001193125-26-402820

Filer

Stoke Therapeutics, Inc. (CIK 1623526)